Posts

A New Blue: Mysterious origin of the ribbontail ray’s e...

Researchers have discovered the unique nanostructures responsible for the electr...

Exploring the casque anatomy of aerial jousting helmete...

New research reveals how the surprising internal anatomy of the helmeted hornbil...

International summit of experts in nuclear physics at t...

More than two hundred international experts will take part in the 10th Internati...

Scientists discover new T cells and genes related to im...

Researchers led by Yasuhiro Murakawa at the RIKEN Center for Integrative Medical...

Effects of visual and auditory instructions on space st...

Firstly, the authors provided a detailed explanation of the experimental methods...

Desert-loving fungi and lichens pose deadly threat to 5...

The Negev desert of southern Israel is renowned for its unique rock art. Since a...

European Regulatory Agency Gives AstraZeneca’s Covid-19...

Despite having exited the COVID-19 vaccine market this year, pharma giant AstraZ...

Sanofi’s Dupixent Injectable Approved by the EU to Trea...

Sanofi and Regeneron gained approval from the European Union for expanded use of...

Deal on Cancer ADC Gets Canceled by Eisai and Bristol M...

Eisai will terminate a partnership on a dual-action lung and ovarian cancer medi...

Johnson & Johnson gains FDA and EC approvals for TB tre...

Johnson & Johnson (J&J) has received the US FDA and EC approvals for SIRTURO (be...

Moderna’s mRNA influenza vaccine receives $176m boost

Moderna has received a grant of $176m through the RRPV Consortium to expedite th...

Left in limbo: When pharma halts rare disease research

Academic institutions and nonprofit organisations are jumping in to save access ...

Eli Lilly’s donanemab wins FDA approval for Alzheimer’s...

Leqembi will now face a challenger as donanemab enters the market under the bran...

Beacon secures $170m to advance ophthalmic gene therapies

Beacon’s lead candidate AGTC-501 is currently in a Phase II/III clinical trial f...

Biogen completes $1.15bn HI-Bio acquisition to expand i...

The takeover, which includes the candidate felzartamab, for immune-mediated dise...

Emergent scores US medical countermeasure contracts wor...

Emergent will supply vaccines for anthrax and smallpox, VIV for treating smallpo...